First Time Loading...
V

VIVA Biotech Holdings
HKEX:1873

Watchlist Manager
VIVA Biotech Holdings
HKEX:1873
Watchlist
Price: 0.62 HKD 1.64% Market Closed
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one VIVA Biotech Holdings stock under the Base Case scenario is 2.47 HKD. Compared to the current market price of 0.62 HKD, VIVA Biotech Holdings is Undervalued by 75%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
2.47 HKD
Undervaluation 75%
Relative Value
Price
V
Worst Case
Base Case
Best Case

Valuation Multiples

0.6
P/S
P/S
Price to Sales
0.6
vs History
61
vs Industry
91
Median 3Y
1.3
Median 5Y
1.1
Industry
3.9
Forward
0.4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
23
Median 3Y
-4.7
Median 5Y
-9.1
Industry
30.3
Forward
2.8
More Details
2
P/OCF
P/OCF
Price to OCF
2
vs History
61
vs Industry
50
Median 3Y
15.2
Median 5Y
4.7
Industry
23.2
More Details
3.5
P/FCFE
P/FCFE
Price to FCFE
3.5
vs History
25
vs Industry
35
Median 3Y
2.9
Median 5Y
-18.2
Industry
26.9
More Details
0.3
P/B
P/B
Price to Book Value
0.3
vs History
90
vs Industry
89
Median 3Y
0.8
Median 5Y
1.7
Industry
2.5
More Details
0.5
EV/S
EV/S
Enterprise Value to Sales
0.5
vs History
61
vs Industry
87
Median 3Y
1.8
Median 5Y
1
Industry
3.8
Forward
0.4
More Details
1.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.6
vs History
61
vs Industry
82
Median 3Y
5.8
Median 5Y
2.8
Industry
7.7
More Details
2.8
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
2.8
vs History
61
vs Industry
48
Median 3Y
9.5
Median 5Y
4.9
Industry
16.8
Forward
1.9
More Details
5.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
5.5
vs History
59
vs Industry
43
Median 3Y
16
Median 5Y
8.7
Industry
22
Forward
2.9
More Details
1.9
EV/OCF
EV/OCF
Enterprise Value to OCF
1.9
vs History
61
vs Industry
51
Median 3Y
26.1
Median 5Y
3.9
Industry
21.1
More Details
2.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
2.9
vs History
22
vs Industry
36
Median 3Y
-11.6
Median 5Y
-15.9
Industry
27.6
More Details
0.2
EV/IC
EV/IC
Enterprise Value to IC
0.2
vs History
90
vs Industry
89
Median 3Y
0.6
Median 5Y
1.2
Industry
2.4
More Details

Multiples Across Competitors

Competitors Multiples
VIVA Biotech Holdings Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
VIVA Biotech Holdings
HKEX:1873
1.3B HKD 0.6 -10.6 2.8 5.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
220.9B USD 5.2 36.8 22.8 33.4
US
Danaher Corp
NYSE:DHR
182.8B USD 4.2 22.7 16.5 20.3
CH
Lonza Group AG
SIX:LONN
37.5B CHF 5.6 57.2 19.7 28.9
KR
Samsung Biologics Co Ltd
KRX:207940
54.9T KRW 14.9 64 33.7 48.6
US
IQVIA Holdings Inc
NYSE:IQV
40.3B USD 2.7 29.7 16.3 25.1
US
Agilent Technologies Inc
NYSE:A
40.3B USD 6 32.6 26.1 31.4
US
Mettler-Toledo International Inc
NYSE:MTD
26.9B USD 7.1 34.1 23.8 26.5
US
West Pharmaceutical Services Inc
NYSE:WST
26.9B USD 9.2 47.3 32.8 39.9
IE
ICON PLC
NASDAQ:ICLR
24.9B USD 3 36.4 16.5 25.4
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR 7.2 75.5 32.4 53.2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.